odan clobetasol spray
odan laboratories ltd - clobetasol propionate - spray - 0.05% - clobetasol propionate 0.05% - corticosteroids
odan-cyclopentolate solution
odan laboratories ltd - cyclopentolate hydrochloride - solution - 1% - cyclopentolate hydrochloride 1% - mydriatics
odan-cyclopentolate solution
odan laboratories ltd - cyclopentolate hydrochloride - solution - 0.5% - cyclopentolate hydrochloride 0.5% - mydriatics
temodal 5 mg
merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 5 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.
temodal 20 mg
merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 20 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.
temodal 100 mg
merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 100 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.
temodal 250 mg
merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 250 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.
temodal
merck sharp & dohme b.v. - temozolomide - glioma; glioblastoma - antineoplastic agents - temodal hard capsules is indicated for the treatment of:adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment;children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
odan-prochlorperazine suppository
odan laboratories ltd - prochlorperazine - suppository - 10mg - prochlorperazine 10mg - phenothiazines
rodan and fields redefine regimen for the appearance of lines, pores and loss of firmness- octocrylene, avobenzone, octisalate,
rodan & fields - avobenzone 3%, homosalate 2.5%, octisalate 5%, octocrylene 2.7% - sunscreen - helps prevent sunburn. - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun.